Ambrosia Biosciences takes over ex-Pfizer space in Boulder
BOULDER — Ambrosia Biosciences Inc., a recently formed drug-discovery company, has moved into Pfizer Inc.’s (NYSE: PFE) previously shuttered Boulder research and development facilities and closed a $25 million Series A fundraising round. The company — …